| Document |
Document Title |
|
WO/2001/046135A1 |
A process for preparing chiral isomers of N-protected 2-azetidinemethanol compounds of formula (5), particularly N-(phenylmethyl)-2-azetidinemethanol and N-BOC-2-azetidinemethanol, and especially the (R)-isomers thereof, as well as O-sub...
|
|
WO/2001/044403A1 |
Fluorescent monomers of formula (I) and (II) wherein M is selected from the group consisting of hydrogen, sodium, potassium, cesium, rubidium, lithium and ammonium, and n is selected from the group consisting of 1, 2, 3, 4, 6 and 9; are ...
|
|
WO/2001/044174A1 |
Compounds useful as surface coating agents, including compounds of Formula (I), wherein X¿1? comprises a first photoreactive species; X¿2? comprises a second photoreactive species; Y comprises a nonpolymeric core molecule comprising an...
|
|
WO/2001/044173A1 |
An improved process for removing trace solvent from a material comprises rewetting the product with water during the drying process. Finished products such as suramin are produced efficiently to a high quality on a factory scale.
|
|
WO/2001/044261A1 |
Process for treating filtration panels obtained by the filtration of oils containing sulfonates of earth-alkaline metal, the above filtration being carried out in the presence of filter aids essentially consisting of siliceous material, ...
|
|
WO/2001/042227A1 |
Triazolone compounds of general formula [I], fungicides containing the same as the active ingredient; and intermediates for the production of the compounds. In said formula, R?1¿ is optionally substituted phenyl or the like; and T is op...
|
|
WO/2001/042226A1 |
The present invention relates to a compound of formula (I) wherein R?1¿ is an unsubstituted or substituted hydrocarbon radical having a total of 1 to 10 carbon atoms, preferably 1 to 6 carbon atoms, R?2¿ is an unsubstituted or substitu...
|
|
WO/2001/042202A1 |
The invention discloses compositions which may be prepared in a single DEFI reactor comprising mixtures of (1) DEFI and (2) compound products by reaction of (a) isethionate with fatty acid replacement or (b) fatty acid with isethionate r...
|
|
WO/2001/040167A1 |
A production process by which an onium salt derivative useful as, e.g., an acid generator in resists of the chemical amplification type can be synthesized in high yield. The process comprises reacting an onium salt derivative having a ha...
|
|
WO/2001/040168A1 |
An acetalsulfonate derivative useful as an intermediate for medicines and agricultural chemicals; a process for industrially producing the derivative; and a process for industrially producing a styrene oxide derivative from the acetalsul...
|
|
WO/2001/040172A1 |
The present invention relates to certain tri-substituted phenyl derivatives and analogues of formula (I), to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods...
|
|
WO/2001/040169A1 |
The present invention relates to a reduced particle size form of the compound (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phen
yl] propanoic acid, as shown in formula (I), or a pharmaceutically acceptable salt thereof or a so...
|
|
WO/2001/040171A1 |
The present invention relates to a novel crystalline form of the compound (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phen
yl] propanoic acid, shown by formula (I), or a pharmaceutically-acceptable salt thereof, and solvates ...
|
|
WO/2001/040170A1 |
The present invention relates to certain phenalkyloxy-phenyl derivatives of formula (I) and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for ...
|
|
WO/2001/038299A1 |
The invention relates to a method for producing and purifying substituted benzene sulfonates, whereby a mixture, which contains, in free or bound form, at least one substituted benzene sulfonate or at least one corresponding substituted ...
|
|
WO1999024394A9 |
Amyloid binding compounds which are derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimer's brain in vivo and to diagnose other pathological conditions characterized b...
|
|
WO/2001/038297A1 |
3-(3-Hydroxy-4-methoxyphenyl)-3-methylbutyric acid can be obtained by substituting the substituent at the 3-position of the benzene ring of a butyric acid derivative which can be easily and efficiently produced by reacting a hydroxyl-pro...
|
|
WO/2001/038298A1 |
The invention relates to a method for isolating 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate out of a mixture containing 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate, water and an organic solvent. The inventive method is characterized ...
|
|
WO/2001/036363A1 |
This invention provides a process for preparing acylaromatics comprising reacting an aromatic compound with a carboxylic acid in the presence of a reaction medium comprising polyphosphoric acid and a strong protic acid. In one embodiment...
|
|
WO/2001/036381A1 |
Hydrazone compounds represented by general formula (1) or salts thereof and novel agricultural chemicals (in particular, insecticides and miticides) containing these compounds as the active ingredient formulae (1), G-1, G-2, G-3, wherein...
|
|
WO/2001/036382A1 |
A process for producing a specific benzenesulfonic acid derivative compound, which is suitable for use as a dopant capable of imparting high electrical conductivity to $g(p)-electron conjugated polymers, which comprises contacting a spec...
|
|
WO/2001/030915A1 |
8-(anilino)-1-naphthalenesulfonate (ANS) analogs and methods for their use in analyte detection assays are provided. The subject ANS analogs are characterized by having at least one non-hydrogen substituent on their phenyl moiety and pro...
|
|
WO/2001/028989A1 |
A process for producing a monomer compound represented by general formula (II) (wherein M represents an alkali metal or alkaline earth metal; and n is 0, 1, or 2) by thermally decomposing a compound represented by formula (I) (wherein M ...
|
|
WO/2001/028988A1 |
The invention provides a process that can be used for producing a bis-glycolate ester of 5-sulfo isophthalate metal salt. The process comprises contacting a 5-sulfo isophthalate a metal salt or a dialkyl ester of 5-sulfo isophthalate met...
|
|
WO/2001/027077A2 |
The present application relates to compounds of the fornula (VII), wherein the substituents R?1¿-R?5¿, X and Y are as defined in the description and to compounds of formula (VIII) or formula (IX) and when R?3¿ is in the ortho position...
|
|
WO/2001/027076A1 |
The invention relates to a method for the production of sulfonyl chloride. Said method consists in reacting a salt of sulfinic acid comprising a carbon in sulfur-alpha which includes at least two fluorine atoms with a chlorinating reagen...
|
|
WO/2001/025243A1 |
The present invention relates to compounds that have a novel use as a carbon monoxide source and optionally as a reducing agent in the preparation of transition metal carbonyl complexes. The compounds are in general compounds of formula ...
|
|
WO/2001/023347A1 |
The present invention relates to novel compounds of general formula (I), pharmaceutical formulations comprising these compounds, the use of these compounds as medicaments, the use of these medicaments in the treatment of and/or preventio...
|
|
WO/2001/019771A1 |
Disclosed is a process for the preparation of aryl carboxylate esters by the reaction of a phenol reactant with an esterification agent selected from carboxylic acid anhydrides and carboxylic acid halides in the presence of trifluoroacet...
|
|
WO/2001/017940A1 |
Disclosed is a process for the preparation of alkanoate esters of hydroxybenzenesulfonic acids and salts thereof by the steps of (1) contacting or reacting phenol with an alkanoic acid in the presence of trifluoroacetic acid (TFA) and tr...
|
|
WO/2001/016060A1 |
A method of converting Compound A (1,3-dehydro-cyclopenta[1]phenanthren-2-one) to Compound C (1H-cyclopenta[1]phenanthren) in situ in a single reactor is disclosed.
|
|
WO/2001/014327A1 |
The invention relates to 1,3-disubstituted-3-oxopropane-1-sulphonic acids and sulphonates and pure enantiomers thereof. The invention further relates to the use of enantiomerically enriched 1,3-disubstituted-3-oxopropane-1-sulphonic acid...
|
|
WO/2001/012591A1 |
Methods for treating conditions associated with hyperglycemia, especially Type II diabetes, with novel naphthylsulfonic acids and related compounds are provided. Compounds of formula (1) where: R?1¿ and R?2¿ are, independently, hydroge...
|
|
WO/2001/010817A1 |
This invention relates to a method for preparing 4-substituted-4-cyanocyclohexane carboxylates by forming the cyclohexane ring by treating a $g(a),$g(a)-bis(2-haloethyl)-4-benzeneacetonitrile with a dialkyl malonate and decarboxylating t...
|
|
WO/2001/010827A1 |
$g(a)-Amino hydroxamic acid derivative of formula (I), in which R is C¿2?-C¿7?-alkyl, which is mono-, di- or trisubstituted by halogen, nitro, lower acyloxy, trifluoromethoxy, cyano, C¿3?-C¿5?-cycloalkyl or unsubstituted or substitut...
|
|
WO/2001/010810A1 |
A process for the preparation of divinyl stilbene compounds of formula (1), in which X represents (i); (ii); -CN or (iii) characterized by a) diazotisating an amine of formula (2), wherein Z represents bromine, iodine or -NHCOR¿5?, b) r...
|
|
WO/2001/008793A1 |
This invention addresses methods and compositions for providing alkyl diphenyl oxide sulfonic acid blends at useful viscosities for use in surfactants such as DOWFAX - containing surfactants. The low viscosity alkyl diphenyl oxide sulfon...
|
|
WO/2001/007020A2 |
The invention relates to the use of carboxylic acid amides of general formula (I) for inhibiting telomerase, wherein A, B and R¿1? to R¿5? are defined as per claim (1). The invention also relates to novel carboxylic acid amides of gene...
|
|
WO/2001/005754A1 |
The invention relates to a process for the preparation of 2-methoxy-4-(N-t-butylaminocarbonyl) benzenesulfonyl chloride by sulfonating m-hydroxybenzoic acid, methylating the hydroxy group of the resulting sulfonic acid or its salt, trans...
|
|
WO/2001/005755A1 |
The present invention is directed to detergent compositions, comprising aryl-alkane sulfonate produced by paraffin isometization followed by paraffin dehydrogenation, then by alkylation of an aryl compound by a lightly branched olefin, t...
|
|
WO/2001/005925A1 |
Novel metal complexes of tripodal ligands are useful as catalysts to enhance the action of peroxygen compounds in washing, cleaning and disinfecting processes.
|
|
WO/2001/004910A1 |
The invention concerns the use of sulphonic and phosphonic acids functionalised with plasticizing groups as dopants of conductive polyaniline films and conductive composite materials based on polyaniline. Said acids correspond to formula...
|
|
WO/2001/002348A1 |
The invention concerns a method for preparing sulphonate salts, alkaline or alkaline-earth, corresponding to anion of general formula (I): (R-CF¿2?-SO¿3??-¿)¿n?, through alkaline hydrolysis of sulphonyl chlorides corresponding to for...
|
|
WO/2001/000608A1 |
Racemic or optically pure N-(4-cyano-3-trifluoromethylphenyl)-3-(4 -fluorophenylsulphonyl)-2-hydroxy-2-methylpropionamide of formula (I) is prepared by the following process: 2,3-dihydroxy-2-methylpropionic acid of formula (VII) is react...
|
|
WO/2001/000572A1 |
A process which comprises: the step of contacting a fatty acid alkyl ester with a sulfonating gas in the presence of a discoloration inhibitor to sulfonate the ester; the step of esterifying the product of the sulfonation step with a low...
|
|
WO/2000/078713A1 |
A vitamin K adduct, particularly suitable as vitamin supplement for feeds, constituted by menadione bisulfite bonded with an appropriate ion-exchange resin and exceptionally stabilized thereby. The adduct can be used as an antihemorrhagi...
|
|
WO/2000/076960A1 |
The invention relates to a process for the preparation of fungicides consisting of N-acyl derivatives of methyl N-(2,6-dimethylphenyl)D-alaninate having formula (I) with high yields and with a high optical purity.
|
|
WO/2000/073289A1 |
The invention relates to novel aryl-substituted S(O)¿m? cycles of formula (I), in which F?1¿, F?2¿, G, V, W, X, Y, Z and m have the meanings defined in the description. The invention further relates to methods for producing said cycle...
|
|
WO/2000/073264A1 |
Compounds having formula (I), inhibit cellular proliferation. Processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
|
|
WO/2000/073391A1 |
An aromatic amino sulfonic acid compound is purified by a process including steps of: (a) dissolving the aromatic amino sulfonic acid compound in aqueous medium having a basic pH; (b) acidifying the aqueous medium with acetic acid to pre...
|
